PMID- 29602943
OWN - NLM
STAT- MEDLINE
DCOM- 20181016
LR  - 20190609
IS  - 1941-5923 (Electronic)
IS  - 1941-5923 (Linking)
VI  - 19
DP  - 2018 Mar 31
TI  - Hemoptysis After CardioMEMS Implantation: Case Report and Review.
PG  - 382-385
AB  - BACKGROUND The CardioMEMS heart failure system is a small sensor that is placed 
      in a branch pulmonary artery for ambulatory monitoring of pulmonary artery 
      pressures. CardioMEMS has been approved for use in the United States in patients 
      with New York Heart Association (NYHA) class III heart failure and frequent 
      hospitalizations. In this report we describe a patient who had hemoptysis after 
      CardioMEMS implantation. Further, we discuss possible etiologies for the 
      occurrence of hemoptysis and suggest strategies to minimize this risk. CASE 
      REPORT The patient was a 79-year-old female with NYHA class III heart failure 
      with non-ischemic cardiomyopathy (LVEF 40%) and chronic atrial fibrillation who 
      was referred for CardioMEMS implantation. The procedure was completed 
      uneventfully. The patient was transferred out of the procedure suite to the 
      recovery area where she developed a slight cough approximately 20 minutes after 
      the implantation. Within a few coughs the patient started having hemoptysis. She 
      was transferred to the cardiac intensive care unit for observation. She was kept 
      off warfarin and aspirin and her hemoptysis resolved 3 days later. While the 
      exact etiology of hemoptysis in this patient was unclear, we felt that it may 
      have been precipitated by a minor wire-induced distal branch pulmonary artery 
      injury. CONCLUSIONS Our report discusses hemoptysis as a potential 
      life-threatening complication of CardioMEMS sensor implantation while suggesting 
      possible etiologies and avoidance strategies. As the utilization of this 
      technology expands in the years to come, a more comprehensive national registry 
      for surveillance of device related complications will be crucial.
FAU - Rali, Aniket S
AU  - Rali AS
AD  - Department of Cardiovascular Diseases, University of Kansas Medical Center, 
      Kansas City, KS, USA.
FAU - Shah, Zubair
AU  - Shah Z
AD  - Department of Cardiovascular Diseases, University of Kansas Medical Center, 
      Kansas City, KS, USA.
FAU - Sauer, Andrew J
AU  - Sauer AJ
AD  - Department of Cardiovascular Diseases, University of Kansas Medical Center, 
      Kansas City, KS, USA.
FAU - Gupta, Kamal
AU  - Gupta K
AD  - Department of Cardiovascular Diseases, University of Kansas Medical Center, 
      Kansas City, KS, USA.
LA  - eng
PT  - Case Reports
PT  - Journal Article
PT  - Review
DEP - 20180331
PL  - United States
TA  - Am J Case Rep
JT  - The American journal of case reports
JID - 101489566
SB  - IM
MH  - Aged
MH  - Angiography
MH  - Blood Pressure Monitoring, Ambulatory/*instrumentation
MH  - Electrodes, Implanted/*adverse effects
MH  - Equipment Failure
MH  - Female
MH  - Heart Failure/physiopathology/*surgery
MH  - Hemoptysis/diagnosis/*etiology
MH  - Humans
MH  - Lab-On-A-Chip Devices/*adverse effects
MH  - Pulmonary Artery/*injuries
MH  - Pulmonary Wedge Pressure/physiology
MH  - Vascular System Injuries/*complications/diagnosis
PMC - PMC5890615
COIS- Conflict of interest: None declared Conflicts of interest None.
EDAT- 2018/04/01 06:00
MHDA- 2018/10/17 06:00
PMCR- 2018/03/31
CRDT- 2018/04/01 06:00
PHST- 2018/04/01 06:00 [entrez]
PHST- 2018/04/01 06:00 [pubmed]
PHST- 2018/10/17 06:00 [medline]
PHST- 2018/03/31 00:00 [pmc-release]
AID - 908508 [pii]
AID - 10.12659/ajcr.908508 [doi]
PST - epublish
SO  - Am J Case Rep. 2018 Mar 31;19:382-385. doi: 10.12659/ajcr.908508.